Omega Healthcare Q3 net income rises

Omega Healthcare Investors,

30/10/2025 20:31

Overview

Omega Q3 net income rises to $185 mln, up from $115 mln in Q3 2024

Company increases full-year AFFO guidance

Omega entered into new $2.3 bln senior unsecured credit facility

Outlook

Omega raises 2025 AFFO guidance to $3.08-$3.10 per share

Company assumes no additional operators on cash-basis for revenue recognition

Omega plans $15 mln in asset sales for 2025

Result Drivers

NEW INVESTMENTS - Omega completed $151 mln in new investments in Q3, including real estate acquisitions and loans

CREDIT FACILITY - Entered a new $2.3 bln senior unsecured credit facility, replacing previous $1.45 bln facility

JOINT VENTURE - Acquired 49% equity interest in a JV with Saber for $222 mln, involving 64 facilities

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Net Income
$185 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the specialized reits peer group is "buy"

Wall Street's median 12-month price target for Omega Healthcare Investors Inc is $44.00, about 10.2% above its October 29 closing price of $39.53

Press Release: ID:nBwGpLgDa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)